Toronto Dominion Bank
KYNB

Toronto Dominion Bank’s Kyntra Bio KYNB Stock Holding History

Toronto Dominion Bank’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-4
Closed -$78 – 1652
2023
Q3 		$78 Hold
4
– – ﹤0.01% 1700
2023
Q2 		$0 Buy
+4
New +$1.65K ﹤0.01% 1582
2022
Q1 		– Sell
-5,205
Closed -$1.83M – 1602
2021
Q4 		$1.83M Buy
+5,205
New +$1.62M ﹤0.01% 864
2020
Q4 		– Sell
-3
Closed -$3K – 1373
2020
Q3 		$3K Buy
3
+2
+200% +$2.15K ﹤0.01% 1135
2020
Q2 		$1K Buy
+1
New +$929 ﹤0.01% 1194

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Toronto Dominion Bank's KYNB Position: Q4 2023 in Review

Toronto Dominion Bank sold out of Kyntra Bio (KYNB) in Q4 2023, closing a stake of 4 shares — an estimated $78 sold.

Toronto Dominion Bank first reported a position in KYNB in Q2 2020 and held it in 5 quarters. The position peaked at $1.83M in Q4 2021. 100 funds tracked by Wall St. Rank hold KYNB as of Q4 2023.

  • Toronto Dominion Bank reported no remaining Kyntra Bio position as of Q4 2023 after selling out during the quarter.
  • Toronto Dominion Bank sold 4 Kyntra Bio shares in Q4 2023, an estimated $78.
  • Toronto Dominion Bank first reported a position in Kyntra Bio in Q2 2020 and held it in 5 quarters.
  • Toronto Dominion Bank's Kyntra Bio position peaked at $1.83M in Q4 2021.
  • 100 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2023.

Based on Toronto Dominion Bank's 13F filing for Q4 2023, filed 13 Feb 2024.